Weight Bearing Status Post-hip Arthroscopy

April 11, 2024 updated by: Craig Mauro, University of Pittsburgh

Weight Bearing as Tolerated (WBAT) Following Hip Arthroscopic Labral Repair and Femoroplasty.

This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Cadaveric studies demonstrate that minimal force during weight bearing is distributed through labrum. Therefore, progressing weight bearing earlier in these patients post operatively may help progress faster and improve outcomes. Data collected will include demographic information, radiological data, operative procedures and PRO data.

Study Overview

Detailed Description

The study will be conducted at UPMC St. Margaret's Hip Preservation Program. Consented patients who undergo acetabular labral repair and femoroplasty will be included in randomization of weight-bearing status. Two separate protocols will be created to indicate weight bearing status, either WBAT immediately post-op or FFWB immediately post-op, to distribute to rehabilitation staff to ensure compliance. Immediately after the surgical procedure, the surgeon will be blinded and a randomized pamphlet with post-operative instructions with weight bearing education will be given to PACU nursing staff to educate patients and fit crutches.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15238
        • UPMC Hip Preservation Program

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age>= 12 years
  • Diagnoses: femoroacetabular impingement and hip labral tears.
  • Surgical procedures performed: Hip arthroscopy with femoroplasty and labral repair.
  • Surgery completed at UPMC Children's or UPMC St. Margaret's Hospital
  • unilateral and bilateral hip patients

Exclusion Criteria:

  • MSK tumor-related FAI or dysplasia
  • generalized hypermobility
  • revision surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Weight bearing as tolerated (WBAT) immediately following surgery.
Subjects will be able to self-select weight bearing based on pain and confidence in surgical hip.
Subject will be provided standard of care physical therapy following surgical intervention, except will be able to self-select weight bearing based on pain and confidence.
Active Comparator: Flat foot weight bearing (FFWB) for 2 weeks after surgery.
Subjects will be limited to FFWB, approx 20lbs through the surgical hip.
Subject will be provided standard of care physcial therapy following surgical intervention except

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Hip Outcome Tool 12 (iHot-12)
Time Frame: up to 6 months post-operative

Scoring ranges from 0-100

  • each question is rated from 0-100 and final score is the mean of all questions answered by subject
  • higher scoring indicating higher quality of life due to hip function
up to 6 months post-operative
Hip and Groin Outcome Score (HAGOS)
Time Frame: up to 6 months post-operative

This outcome includes 6 subscales, these are scored independently, and no aggregate scoring is calculated as each section assesses different dimensions separately.

Subscales (raw scores for each subscale converted to a 0-100 scale with higher score indicating higher level of function):

  • Pain
  • Symptoms
  • Activities of Daily Life
  • Function in Sport and recreation
  • Participation in Physical Activities
  • hip and groin-related quality of life
up to 6 months post-operative
Hip Outcome Score (HOS) ADL
Time Frame: up to 6 months post-operative

Outcome assessing function with activities of daily living. Higher score is given for higher level of function and lower score indicating reduced function.

0-68 aggregate scoring converted to 0-100 scale.

up to 6 months post-operative
Hip Outcome Score (HOS) Sport
Time Frame: up to 6 months post-operative

Outcome assessing function/difficulty completing dynamic activities associated with sports participation. Higher score is given for higher level of function and lower score indicating reduced function.

0-36 aggregate scoring converted to 0-100 scale.

up to 6 months post-operative
Tampa Scale for Kinesiophobia-11
Time Frame: up to 6 months post-operative
Outcome measure assessing fear of pain with movement. Scores range from 11 to 44. Higher scores indicate greater fear of movement
up to 6 months post-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric strength measures hip add, abd, ER, and extension
Time Frame: 6-week, 3 months, and 6-month post-operative
Strength measures will be taken isometrically at post-operative follow ups.
6-week, 3 months, and 6-month post-operative
Diagnostic ultrasound assessment of bilateral anterior hip capsule thickness
Time Frame: 3 months post-operative

Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.

Ultrasound will measure the following:

1.Assess the bilateral hip anterior capsule in all patients, assessing for internal consistency or changes in capsular thickness from side to side. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm.

3 months post-operative
Diagnostic ultrasound assessment of incision widening
Time Frame: 3 months post-operative

Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.

1. Evaluation of capsular incision widening, cyst, attenuation and thinning from established norms. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm

3 months post-operative
Diagnostic ultrasound for focal echogenic adhesions
Time Frame: 3 months post-operative

Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.

1. Evaluate for focal echogenic adhesions or dyskinetic motion between capsule and overlying iliopsoas complex with activation of hip flexion.

3 months post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

July 28, 2025

Study Registration Dates

First Submitted

January 10, 2023

First Submitted That Met QC Criteria

February 7, 2023

First Posted (Actual)

February 9, 2023

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 11, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY22080053

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acetabular Labral Tear

Clinical Trials on Weight Bearing as tolerated (WBAT) immediately following surgery.

3
Subscribe